177 related articles for article (PubMed ID: 6717135)
1. [Usefulness of increasing the proportion of carbidopa to levodopa in the long-term treatment of Parkinson's disease].
Bermejo Pareja F; Martínez-Martín P
Med Clin (Barc); 1984 Feb; 82(7):305-10. PubMed ID: 6717135
[No Abstract] [Full Text] [Related]
2. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
Lombardo L; De la Garza R
Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
[TBL] [Abstract][Full Text] [Related]
3. Comparison of enteric-coated levodopa with levodopa-carbidopa combination. A double-blind crossover trial.
Gilligan B; Wodak J; Stark R; O'Halloran M
Med J Aust; 1979 Aug; 2(4):205-7. PubMed ID: 390336
[TBL] [Abstract][Full Text] [Related]
4. Use of carbidopa as an adjuvant to levodopa/carbidopa therapy in patients with Parkinson's disease.
Lieberman AN; Gopinathan G; Neophytides A; Pasternack P
N Y State J Med; 1986 Dec; 86(12):655-6. PubMed ID: 3468386
[No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
Londoõ R
Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
[TBL] [Abstract][Full Text] [Related]
6. Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease.
Busk K; Nyholm D
Parkinsonism Relat Disord; 2012 Sep; 18(8):1000-1. PubMed ID: 22546333
[No Abstract] [Full Text] [Related]
7. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
Pahwa R; Koller WC
Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
[No Abstract] [Full Text] [Related]
9. [Combined therapy of carbidopa and levodopa in Parkinson's disease].
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):201-4. PubMed ID: 4075908
[No Abstract] [Full Text] [Related]
10. The beneficial effect of chronic lisuride administration compared with levodopa in Parkinson's disease.
Rabey JM; Streifler M; Treves T; Korczyn AD
Adv Neurol; 1990; 53():451-5. PubMed ID: 2122652
[No Abstract] [Full Text] [Related]
11. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
[TBL] [Abstract][Full Text] [Related]
12. Off-period screaming accompanying motor fluctuations in Parkinson's disease.
Steiger MJ; Quinn NP; Toone B; Marsden CD
Mov Disord; 1991; 6(1):89-90. PubMed ID: 2005932
[No Abstract] [Full Text] [Related]
13. Sinemet in Parkinson's disease: efficacy with and without food.
Bozek CB; Suchowersky O; Purves S; Calne S; Calne DB
Clin Neuropharmacol; 1986; 9(2):196-9. PubMed ID: 3708604
[No Abstract] [Full Text] [Related]
14. First emergence of "delayed-on" and "dose failure" phenomena in a patient with Parkinson's disease following vagotomy.
Djaldetti R; Achiron A; Ziv I; Melamed E
Mov Disord; 1994 Sep; 9(5):582-3. PubMed ID: 7990855
[No Abstract] [Full Text] [Related]
15. The effects of combining carbidopa with levodopa for Parkinson's disease.
Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB
Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406
[No Abstract] [Full Text] [Related]
16. L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients.
Elizan TS; Yahr MD; Moros DA; Mendoza MR; Pang S; Bodian CA
Adv Neurol; 1990; 53():431-5. PubMed ID: 2122649
[No Abstract] [Full Text] [Related]
17. Sinemet CR for Parkinson's disease.
Med Lett Drugs Ther; 1991 Oct; 33(854):92-3. PubMed ID: 1895993
[No Abstract] [Full Text] [Related]
18. One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease.
Diamond SG; Markham CH
Adv Neurol; 1984; 40():537-9. PubMed ID: 6695633
[No Abstract] [Full Text] [Related]
19. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
[TBL] [Abstract][Full Text] [Related]
20. Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa.
Metman LV; Hoff J; Mouradian MM; Chase TN
Mov Disord; 1994 Jul; 9(4):463-5. PubMed ID: 7969216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
